Alpha-defensin-dependent enhancement of enteric viral infection

PLoS Pathogens

Volumn 13, Issue 6, 2017, Pages

  Wilson, Sarah S ^a   Bromme, Beth A ^a   Holly, Mayumi K ^a   Wiens, Mayim E ^a   Gounder, Anshu P ^a   Sul, Youngmee ^a   Smith, Jason G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN;

ADENOVIRUS INFECTION; ANIMAL CELL CULTURE; ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; DEPENDENT ENHANCEMENT; ENTERIC VIRAL INFECTION; ENZYME INHIBITION ASSAY; GENE EXPRESSION ASSAY; IMMUNOFLUORESCENCE; MASTADENOVIRUS; MOUSE; MOUSE ADENOVIRUS 2; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; RNA EXTRACTION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS SHEDDING; ADENOVIRIDAE; ANIMAL; C57BL MOUSE; FEMALE; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; PHYSIOLOGY; SMALL INTESTINE; VIROLOGY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ALPHA-DEFENSINS; ANIMALS; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; VIRUS SHEDDING;

EID: 85021822370     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006446     Document Type: Article

References (46)

1. Wilson SS, Wiens ME, Holly MK, Smith JG, Defensins at the Mucosal Surface: Latest Insights into Defensin-Virus Interactions. J Virol. 2016;90(11):5216–8. Epub Mar 23. doi: 10.1128/JVI.00904-15 27009960.
2. Wilson SS, Wiens ME, Smith JG, Antiviral mechanisms of human defensins. J Mol Biol. 2013;425(24):4965–80. doi: 10.1016/j.jmb.2013.09.038 24095897; PubMed Central PMCID: PMC3842434.
3. Ouellette AJ, Paneth cell alpha-defensins in enteric innate immunity. Cell Mol Life Sci. 2011;68(13):2215–29. Epub 2011/05/12. doi: 10.1007/s00018-011-0714-6 21560070.
4. Smith JG, Silvestry M, Lindert S, Lu W, Nemerow GR, Stewart PL, Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog. 2010;6(6):e1000959. Epub 2010/06/30. doi: 10.1371/journal.ppat.1000959 20585634; PubMed Central PMCID: PMC2891831.
5. Wilson SS, Tocchi A, Holly MK, Parks WC, Smith JG, A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions. Mucosal Immunol. 2015;8(2):352–61. Epub Aug 13, 2014. doi: 10.1038/mi.2014.72 25118165; PubMed Central PMCID: PMC4326599.
6. Date S, Sato T, Mini-gut organoids: reconstitution of the stem cell niche. Annu Rev Cell Dev Biol. 2015;31:269–89. doi: 10.1146/annurev-cellbio-100814-125218 26436704.
7. Schwank G, Andersson-Rolf A, Koo BK, Sasaki N, Clevers H, Generation of BAC transgenic epithelial organoids. PLoS One. 2013;8(10):e76871. doi: 10.1371/journal.pone.0076871 24204693; PubMed Central PMCID: PMC3800075.
8. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science. 1999;286(5437):113–7. 10506557.
9. Spindler KR, Moore ML, Cauthen AN, Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith AL, Mouse Adenoviruses. In: The Mouse in Biomedical Research. 2. Second ed.Burlington, MA: Academic Press; 2007. p. 49–65.
10. Tirumuru N, Pretto CD, Castro Jorge LA, Spindler KR, Mouse Adenovirus Type 1 Early Region 1A Effects on the Blood-Brain Barrier. mSphere. 2016;1(2). doi: 10.1128/mSphere.00079-16 27303733; PubMed Central PMCID: PMCPMC4894691.
11. de Felipe P, Luke GA, Hughes LE, Gani D, Halpin C, Ryan MD, E unum pluribus: multiple proteins from a self-processing polyprotein. Trends Biotechnol. 2006;24(2):68–75. doi: 10.1016/j.tibtech.2005.12.006 16380176.
12. Selsted ME, Miller SI, Henschen AH, Ouellette AJ, Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol. 1992;118(4):929–36. 1500431.
13. Gounder AP, Wiens ME, Wilson SS, Lu W, Smith JG, Critical determinants of human alpha-defensin 5 activity against non-enveloped viruses. J Biol Chem. 2012;287(29):24554–62. Epub 2012/05/29. doi: 10.1074/jbc.M112.354068 22637473; PubMed Central PMCID: PMC3397880.
14. Gounder AP, Myers ND, Treuting PM, Bromme BA, Wilson SS, Wiens ME, et al. Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection. PLoS Pathog. 2016;12(3):e1005474. doi: 10.1371/journal.ppat.1005474 26933888; PubMed Central PMCID: PMC4774934.
15. Kuss SK, Best GT, Etheredge CA, Pruijssers AJ, Frierson JM, Hooper LV, et al. Intestinal Microbiota Promote Enteric Virus Replication and Systemic Pathogenesis. Science. 2011;334(6053):249–52. doi: 10.1126/science.1211057 21998395.
16. Robinson CM, Jesudhasan PR, Pfeiffer JK, Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell host & microbe. 2014;15(1):36–46. doi: 10.1016/j.chom.2013.12.004 24439896; PubMed Central PMCID: PMC3920179.
17. Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, Wheadon M, et al. Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science. 2015;347(6219):266–9. doi: 10.1126/science.1258025 25431490.
18. Kane M, Case LK, Kopaskie K, Kozlova A, MacDearmid C, Chervonsky AV, et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science. 2011;334(6053):245–9. doi: 10.1126/science.1210718 21998394; PubMed Central PMCID: PMC3519937.
19. Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, et al. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016. doi: 10.1126/science.aaf5211 27562956.
20. Daher KA, Selsted ME, Lehrer RI, Direct inactivation of viruses by human granulocyte defensins. J Virol. 1986;60(3):1068–74. 3023659.
21. Wiens ME, Wilson SS, Lucero CM, Smith JG, Defensins and viral infection: dispelling common misconceptions. PLoS Pathog. 2014;10(7):e1004186. doi: 10.1371/journal.ppat.1004186 25033215; PubMed Central PMCID: PMC4102581.
22. Taylor A, Foo SS, Bruzzone R, Dinh LV, King NJ, Mahalingam S, Fc receptors in antibody-dependent enhancement of viral infections. Immunol Rev. 2015;268(1):340–64. doi: 10.1111/imr.12367 26497532.
23. Bouhlal H, Chomont N, Requena M, Nasreddine N, Saidi H, Legoff J, et al. Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner. J Immunol. 2007;178(2):1086–95. 17202372. 17202372
24. Tjomsland V, Ellegard R, Che K, Hinkula J, Lifson JD, Larsson M, Complement opsonization of HIV-1 enhances the uptake by dendritic cells and involves the endocytic lectin and integrin receptor families. PLoS One. 2011;6(8):e23542. doi: 10.1371/journal.pone.0023542 21853149; PubMed Central PMCID: PMC3154940.
25. Cheng G, Cox J, Wang P, Krishnan MN, Dai J, Qian F, et al. A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes. Cell. 2010;142(5):714–25. doi: 10.1016/j.cell.2010.07.038 20797779; PubMed Central PMCID: PMCPMC2954371.
26. Klotman ME, Rapista A, Teleshova N, Micsenyi A, Jarvis GA, Lu W, et al. Neisseria gonorrhoeae-Induced Human Defensins 5 and 6 Increase HIV Infectivity: Role in Enhanced Transmission. J Immunol. 2008;180(9):6176–85. 18424739.
27. Rapista A, Ding J, Benito B, Lo YT, Neiditch MB, Lu W, et al. Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment. Retrovirology. 2011;8:45. Epub 2011/06/16. doi: 10.1186/1742-4690-8-45 21672195; PubMed Central PMCID: PMC3146398.
28. Lutschg V, Boucke K, Hemmi S, Greber UF, Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells. Nature communications. 2011;2:391. doi: 10.1038/ncomms1391 21750545.
29. Kawaguchi I, Sasaki A, Boots M, Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains. Proc Biol Sci. 2003;270(1530):2241–7. doi: 10.1098/rspb.2003.2440 14613610; PubMed Central PMCID: PMC1691498.
30. Andraud M, Hens N, Marais C, Beutels P, Dynamic epidemiological models for dengue transmission: a systematic review of structural approaches. PLoS One. 2012;7(11):e49085. doi: 10.1371/journal.pone.0049085 23139836; PubMed Central PMCID: PMC3490912.
31. Zins SR, Nelson CD, Maginnis MS, Banerjee R, O'Hara BA, Atwood WJ, The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing ER traffic and stabilizing the viral capsid. J Virol. 2013;88(2):948–60. doi: 10.1128/JVI.02766-13 24198413; PubMed Central PMCID: PMC3911681.
32. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J, Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. Journal of immunology. 2007;179(6):3958–65. Epub 2007/09/06. 17785833.
33. Szyk A, Wu Z, Tucker K, Yang D, Lu W, Lubkowski J, Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci. 2006;15(12):2749–60. 17088326. doi: 10.1110/ps.062336606
34. Ito T, Tanabe H, Ayabe T, Ishikawa C, Inaba Y, Maemoto A, et al. Paneth cells regulate both chemotaxis of immature dendritic cells and cytokine production from epithelial cells. The Tohoku journal of experimental medicine. 2012;227(1):39–48. Epub 2012/04/26. 22531160.
35. Yang D, Chen Q, Chertov O, Oppenheim JJ, Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol. 2000;68(1):9–14. Epub 2000/07/29. 10914484.
36. Lopez-Gordo E, Denby L, Nicklin SA, Baker AH, The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery. Expert opinion on drug delivery. 2014;11(11):1795–813. doi: 10.1517/17425247.2014.938637 25036189.
37. Tanabe H, Ouellette AJ, Cocco MJ, Robinson WE, JrDifferential effects on human immunodeficiency virus type 1 replication by alpha-defensins with comparable bactericidal activities. J Virol. 2004;78(21):11622–31. Epub 2004/10/14. doi: 10.1128/JVI.78.21.11622-11631.2004 15479803; PubMed Central PMCID: PMC523300.
38. Smith JG, Nemerow GR, Mechanism of adenovirus neutralization by Human alpha-defensins. Cell host & microbe. 2008;3(1):11–9. doi: 10.1016/j.chom.2007.12.001 18191790.
39. Tenge VR, Gounder AP, Wiens ME, Lu W, Smith JG, Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition. PLoS Pathog. 2014;10(9):e1004360. doi: 10.1371/journal.ppat.1004360 25188351; PubMed Central PMCID: PMC4154873.
40. Kudryashova E, Quintyn R, Seveau S, Lu W, Wysocki VH, Kudryashov DS, Human Defensins Facilitate Local Unfolding of Thermodynamically Unstable Regions of Bacterial Protein Toxins. Immunity. 2014;41(5):709–21. doi: 10.1016/j.immuni.2014.10.018 25517613.
41. Nigro G, Rossi R, Commere PH, Jay P, Sansonetti PJ, The cytosolic bacterial peptidoglycan sensor Nod2 affords stem cell protection and links microbes to gut epithelial regeneration. Cell host & microbe. 2014;15(6):792–8. doi: 10.1016/j.chom.2014.05.003 24882705.
42. Kaiko GE, Ryu SH, Koues OI, Collins PL, Solnica-Krezel L, Pearce EJ, et al. The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites. Cell. 2016;165(7):1708–20. doi: 10.1016/j.cell.2016.05.018 27264604.
43. In J, Foulke-Abel J, Zachos NC, Hansen AM, Kaper JB, Bernstein HD, et al. Enterohemorrhagic Escherichia coli reduce mucus and intermicrovillar bridges in human stem cell-derived colonoids. Cellular and molecular gastroenterology and hepatology. 2016;2(1):48–62 e3. doi: 10.1016/j.jcmgh.2015.10.001 26855967; PubMed Central PMCID: PMC4740923.
44. Sato T, Clevers H, Primary mouse small intestinal epithelial cell cultures. Methods Mol Biol. 2013;945:319–28. doi: 10.1007/978-1-62703-125-7_19 23097115.
45. Hemmi S, Vidovszky MZ, Ruminska J, Ramelli S, Decurtins W, Greber UF, et al. Genomic and phylogenetic analyses of murine adenovirus 2. Virus Res. 2011;160(1–2):128–35. Epub 2011/06/21. doi: 10.1016/j.virusres.2011.05.023 21683742.
46. Nepomuceno RR, Pache L, Nemerow GR, Enhancement of gene transfer to human myeloid cells by adenovirus-fiber complexes. Mol Ther. 2007;15(3):571–8. 17180119. doi: 10.1038/sj.mt.6300048